CastleKnight Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-66,700
Closed -$124K – 286
2022
Q2
$124K Hold
66,700
– – 0.02% 229
2022
Q1
$238K Buy
66,700
+43,900
+193% +$216K 0.03% 228
2021
Q4
$196K Buy
+22,800
New +$145K 0.04% 168

Other funds holding LHDX

CastleKnight Management's LHDX Position: Q3 2022 in Review

CastleKnight Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 66,700 shares — an estimated $124K sold.

CastleKnight Management first reported a position in LHDX in Q4 2021 and held it in 3 quarters. The position peaked at $238K in Q1 2022. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • CastleKnight Management reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CastleKnight Management sold 66,700 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $124K.
  • CastleKnight Management first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • CastleKnight Management's Lucira Health, Inc. Common Stock position peaked at $238K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on CastleKnight Management's 13F filing for Q3 2022, filed 14 Nov 2022.